ES2183956T3 - Compuestos de biciclolactama, su empleo y compuesto intermediario en su produccion. - Google Patents

Compuestos de biciclolactama, su empleo y compuesto intermediario en su produccion.

Info

Publication number
ES2183956T3
ES2183956T3 ES96916350T ES96916350T ES2183956T3 ES 2183956 T3 ES2183956 T3 ES 2183956T3 ES 96916350 T ES96916350 T ES 96916350T ES 96916350 T ES96916350 T ES 96916350T ES 2183956 T3 ES2183956 T3 ES 2183956T3
Authority
ES
Spain
Prior art keywords
group
sup
biciclolactama
employment
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96916350T
Other languages
English (en)
Inventor
Kazuo Ogawa
Ichiro Yamawaki
Manabu Kaneda
Takashi Arima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2183956T3 publication Critical patent/ES2183956T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)

Abstract

EL COMPUESTO DE BICICLOLACTAMA DE LA FORMULA (1) TIENE UN EXCELENTE EFECTO ANSIOLITICO, ES DE ELEVADA SEGURIDAD, Y ES UTIL COMO UN COMPONENTE EFECTIVO DE MEDICINAS QUE SON MUY REDUCIDAS EN EFECTOS LATERALES COMO EFECTOS HIPNOTICOS, RELAJANTES DE MUSCULO Y SEDANTES EN DONDE R ES OXO O -OR{SUP,1}, R{SUP,1} ES UN ATOMO DE HIDROGENO O UN GRUPO ACILO, A ES UN GRUPO DE (2) O (3), Q ES UN ATOMO DE HIDROGENO O UN GRUPO DE ALQUILO BAJO, I ES 1 O 2, M ES 0 O 1 Y N ES 0, 1 O 2, CON TAL DE QUE SE EXCLUYA EL CASO DONDE M Y N REPRESENTEN 0 SIMULTANEAMENTE EN DONDE R{SUP,2} ES UN GRUPO BENZOILO O UN GRUPO BENZOILO SUSTITUIDO.
ES96916350T 1995-06-12 1996-06-07 Compuestos de biciclolactama, su empleo y compuesto intermediario en su produccion. Expired - Lifetime ES2183956T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17032995 1995-06-12
JP27465495A JP3161948B2 (ja) 1995-06-12 1995-09-27 ビシクロラクタム化合物

Publications (1)

Publication Number Publication Date
ES2183956T3 true ES2183956T3 (es) 2003-04-01

Family

ID=26493354

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96916350T Expired - Lifetime ES2183956T3 (es) 1995-06-12 1996-06-07 Compuestos de biciclolactama, su empleo y compuesto intermediario en su produccion.

Country Status (10)

Country Link
JP (1) JP3161948B2 (es)
KR (1) KR100220172B1 (es)
AT (1) ATE224369T1 (es)
AU (1) AU697656B2 (es)
CA (1) CA2197178C (es)
DE (1) DE69623747T2 (es)
DK (1) DK0790237T3 (es)
ES (1) ES2183956T3 (es)
PT (1) PT790237E (es)
WO (1) WO1996041796A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE130605T1 (de) * 1990-02-02 1995-12-15 Taiho Pharmaceutical Co Ltd Bicyclolactamderivat.
KR0168508B1 (ko) * 1994-03-28 1999-01-15 고바야시 유키오 항불안약

Also Published As

Publication number Publication date
JPH0959251A (ja) 1997-03-04
PT790237E (pt) 2003-02-28
AU697656B2 (en) 1998-10-15
CA2197178A1 (en) 1996-12-27
KR970704686A (ko) 1997-09-06
KR100220172B1 (ko) 1999-09-01
ATE224369T1 (de) 2002-10-15
DE69623747T2 (de) 2003-05-22
DK0790237T3 (da) 2002-10-14
AU5911896A (en) 1997-01-09
CA2197178C (en) 2001-05-01
DE69623747D1 (de) 2002-10-24
WO1996041796A1 (en) 1996-12-27
JP3161948B2 (ja) 2001-04-25

Similar Documents

Publication Publication Date Title
MX9700249A (es) Compuestos ariltios como agentes antibacteriales yantivirales.
AR003937A1 (es) Compuesto ciclico que tiene efecto antagonico al receptor de taquiquinina, proceso para producirlo y composicion farmaceutica que lo contiene.
ES2033715T3 (es) Un procedimiento para producir un derivado de 2-fenoxipirimidina.
ES2172585T3 (es) Derivado de benzoimidazol.
ES2092345T3 (es) Compuestos organicos de silicio que contienen radicales glicosido, y procesos para su preparacion.
PL339701A1 (en) Acylosulphamoybenzamides, crop protection products containing them and method of obtaining such crop protection products
ES2066794T3 (es) Polietilenglicolcarbaminatos.
ES2139079T3 (es) Compuestos inmunosupresores y antialergicos, tales como n-(3-oxohexanoil)-homoserina-lactona.
DE59106095D1 (de) Vorrichtung für die rekombination von wasserstoff und sauerstoff sowie verwendung der vorrichtung.
ES2115805T3 (es) Ligandos portadores de heteroatomos, y complejos metalicos de los mismos.
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
CO4560475A1 (es) Un producto de carbon modificado
ES2083464T3 (es) Compuestos heterociclicos.
IT7827851A0 (it) 2-cheto-1,4-diazacicloalcani sostituiti e composizioni stabilizzate alla luce ultravioletta contenenti tali composti.
DE59005206D1 (de) Gasgenerator.
ES2080721T3 (es) Agentes tensoactivos de silicona.
ES2022873B3 (es) Termoplasticos de ingenieria que contienen grupos de benzociclobuteno unidos.
ES2070845T3 (es) Agentes quelatantes macrociclicos y sus quelatos.
ATE218576T1 (de) Phosphohalohydrine, verfahren zu deren herstellung und verwendungen
AR246951A1 (es) Un metodo de tratamiento de residuos de destilacion de diisocianato de tolueno y productos formados por dicho tratamiento.
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2169150T3 (es) Compuestos a base de dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
IT8123890A0 (it) Processo per la sintesi di urea.
ES2060583T3 (es) Nuevos derivados de cefalosporina, procedimiento para su obtencion y preparados farmaceuticos correspondientes.
LV12824B (lv) Fibrinogēnu receptoru antagonistu iegūšanas paņēmiens